Login / Signup

Does anti-VEGF bevacizumab improve survival in experimental sepsis?

Emmanuel BesnierEbba BrakenhielmVincent RichardFabienne Tamion
Published in: Critical care (London, England) (2017)
Keyphrases
  • vascular endothelial growth factor
  • septic shock
  • acute kidney injury
  • intensive care unit
  • endothelial cells
  • metastatic colorectal cancer
  • free survival